RESEARCH PROJECTS

International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants.

The OBSTINATE registry.

(OBServaToire INternational des patients traités par Anticoagulants oraux directs au cours du syndrome des anTiphospholipidEs)

Registry supported by the European Forum on Antiphospholipid Antibodies and the Lupus Anticoagulant/Antiphospholipid Antibodies Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis

Inclusion criteria: All thrombotic APS patients according to Sydney criteria treated with a direct oral anticoagulant (rivaroxaban, apixaban, edoxaban, dabigatran).

To participate and to include a patient:

- Contact: Prof. S. Zuily

- Website: electronic CRF (available soon)